+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematology Analyzer Market by Product & Service, Type and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030.

  • PDF Icon

    Report

  • 261 Pages
  • September 2021
  • Region: Global
  • Allied Market Research
  • ID: 5480750
Description Jump to:
The global hematology analyzer market was valued at $1,962.40 million in 2020 and is projected to reach $3,941.10 million by 2030 registering a CAGR of 7.30% from 2021 to 2030.



Hematology is a branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to the blood. Hematology analyzers are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting. Hematology analyzers are used to conduct a complete blood count (CBC), which is usually the first test requested by physicians to determine a patients general health status. A complete blood count includes red blood cell (RBC), white blood cell (WBC), hemoglobin, and platelet counts, as well as hematocrit levels. Other analyses include RBC distribution width, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentrations, WBC differential count in percentage and absolute value, platelet distribution width, platelet mean volume, large platelet cell ratio, platelet criteria.

The main driving factors that drive growth of the hematology analyzer market include, increase in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzer coupled with rising preference towards high sensitivity hematology analyzer further boost the growth of the hematology analyzer market. However, high cost of hematology analyzers owing to advanced features and automation may hamper the growth of the market. Furthermore, stringent regulatory policies for hematology analyzers are also expected to limit growth of the market. In contrast, growth opportunities in emerging economics expected to offer lucrative growth opportunities for players in the hematology analyzer market.

The global hematology analyzer market is segmented on the basis of product & service, type, end user, and region to provide a detailed assessment of the market. By product & service it is classified into instruments, reagent & consumables, and services. By type, it is segmented into fully automated hematology analyzer and semi-automated hematology analyzer. Based on end user, it is categorized into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the hematology analyzer market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of hematology analyzer used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Product & Service

  • Instruments
  • Reagents & Consumables
  • Services

By Type

  • Fully Automated Hematology Analyzers
  • Semi-automated Hematology Analyzers

By End User

  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter Inc.)
  • Bio-Rad Laboratories
  • Boule Diagnostics AB
  • F Hoffmann-La Roche Ltd
  • Hobira Ltd
  • Nihon Kohden Corporation,
  • Siemens Healthineers
  • Stratec SE (Diatron MI Plc.)
  • Sysmex Corporation.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of blood disorders
3.5.1.2. Technological advancements in hematology analyzers
3.5.1.3. Growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer
3.5.2. Restraints
3.5.2.1. High cost of hematology analyzers
3.5.2.2. Stringent regulatory policies for hematology analyzers
3.5.3. Opportunities
3.5.3.1. Growth opportunities in emerging economics
3.5.4. Impact analysis
3.6. COVID-19 Impact analysis on the hematology analyzer market
CHAPTER 4: HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.2.1. Market size and forecast for instruments, by end user
4.2.3. Market analysis, by country
4.3. Reagents and consumables
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.2.1. Market size and forecast for reagents & consumables, by end user
4.3.3. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.2.1. Market size and forecast for services, by end user
4.4.3. Market analysis, by country
CHAPTER 5: HEMATOLOGY ANALYZER MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Fully Automated Hematology Analyzer
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Semi-Automated Hematology Analyzer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: HEMATOLOGY ANALYZER MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Clinical Laboratories
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Research Institutes
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: HEMATOLOGY ANALYZER MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U. S.
7.2.2.1.1. U. S. hematology analyzer market, by product & services
7.2.2.1.2. U. S. hematology analyzer market, by type
7.2.2.1.3. U. S. hematology analyzer market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada hematology analyzer market, by product & services
7.2.2.2.2. Canada hematology analyzer market, by type
7.2.2.2.3. Canada hematology analyzer market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico hematology analyzer market, by product & services
7.2.2.3.2. Mexico hematology analyzer market, by type
7.2.2.3.3. Mexico hematology analyzer market, by end user
7.2.3. North America market size and forecast, by product & services
7.2.4. North America market size and forecast, by type
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany hematology analyzer market, by product & services
7.3.2.1.2. Germany hematology analyzer market, by type
7.3.2.1.3. Germany hematology analyzer market, by end user
7.3.2.2. France
7.3.2.2.1. France hematology analyzer market, by product & services
7.3.2.2.2. France hematology analyzer market, by type
7.3.2.2.3. France hematology analyzer market, by end user
7.3.2.3. UK
7.3.2.3.1. UK hematology analyzer market, by product & services
7.3.2.3.2. UK hematology analyzer market, by type
7.3.2.3.3. UK hematology analyzer market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy hematology analyzer market, by product & services
7.3.2.4.2. Italy hematology analyzer market, by type
7.3.2.4.3. Italy hematology analyzer market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain hematology analyzer market, by product & services
7.3.2.5.2. Spain hematology analyzer market, by type
7.3.2.5.3. Spain hematology analyzer market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe hematology analyzer market, by product & services
7.3.2.6.2. Rest of Europe hematology analyzer market, by type
7.3.2.6.3. Rest of Europe hematology analyzer market, by end user
7.3.3. Europe market size and forecast, by product & services
7.3.4. Europe market size and forecast, by type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan hematology analyzer market, by product & services
7.4.2.1.2. Japan hematology analyzer market, by type
7.4.2.1.3. Japan hematology analyzer market, by end user
7.4.2.2. China
7.4.2.2.1. China hematology analyzer market, by product & services
7.4.2.2.2. China hematology analyzer market, by type
7.4.2.2.3. China hematology analyzer market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia hematology analyzer market, by product & services
7.4.2.3.2. Australia hematology analyzer market, by type
7.4.2.3.3. Australia hematology analyzer market, by end user
7.4.2.4. India
7.4.2.4.1. India hematology analyzer market, by product & services
7.4.2.4.2. India hematology analyzer market, by type
7.4.2.4.3. India hematology analyzer market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea hematology analyzer market, by Product & services
7.4.2.5.2. South Korea hematology analyzer market, by type
7.4.2.5.3. South Korea hematology analyzer market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific hematology analyzer market, by product & services
7.4.2.6.2. Rest of Asia-Pacific hematology analyzer market, by type
7.4.2.6.3. Rest of Asia-Pacific hematology analyzer market, by end user
7.4.3. Asia-Pacific market size and forecast, by product & services
7.4.4. Asia-Pacific market size and forecast, by type
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil hematology analyzer market, by product & services
7.5.2.1.2. Brazil hematology analyzer market, by type
7.5.2.1.3. Brazil hematology analyzer market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia hematology analyzer market, by product & services
7.5.2.2.2. Saudi Arabia hematology analyzer market, by type
7.5.2.2.3. Saudi Arabia hematology analyzer market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa hematology analyzer market, by product & services
7.5.2.3.2. South Africa hematology analyzer market, by type
7.5.2.3.3. South Africa hematology analyzer market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA hematology analyzer market, by product & services
7.5.2.4.2. Rest of LAMEA hematology analyzer market, by type
7.5.2.4.3. Rest of LAMEA hematology analyzer market, by end user
7.5.3. LAMEA market size and forecast, by product & services
7.5.4. LAMEA market size and forecast, by type
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIO-RAD LABORATORIES, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. BOULE DIAGNOSTICS AB
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. DANAHER CORPORATION (BECKMAN COULTER INC.)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. F. HOFFMANN-LA ROCHE AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. HORIBA, LTD.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. NIHON KOHDEN CORPORATION
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. SIEMENS AG
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. STRATEC SE (DIATRON MI PLC)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. SYSMEX CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 02. HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY REGION, 2020-2030($MILLION)
TABLE 03. HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY END USER, 2020-2030($MILLION)
TABLE 04. HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020-2030($MILLION)
TABLE 05. HEMATOLOGY ANALYZER MARKET FOR REAGENTS & CONSUMABLES, BY END USER, 2020-2030($MILLION)
TABLE 06. HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY REGION, 2020-2030($MILLION)
TABLE 07. HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY END USER, 2020-2030($MILLION)
TABLE 08. GLOBAL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 09. HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 10. HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 11. GLOBAL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 12. HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
TABLE 13. HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2030($MILLION)
TABLE 14. HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020-2030($MILLION)
TABLE 15. HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
TABLE 16. HEMATOLOGY ANALYZER MARKET, BY REGION, 2020-2030($MILLION)
TABLE 17. NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 18. U.S. HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 19. U.S. HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 20. U.S. HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21. CANADA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 22. CANADA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 23. CANADA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 24. MEXICO HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 25. MEXICO HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 26. MEXICO HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27. NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 28. NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 29. NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30. EUROPE HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 31. GERMANY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 32. GERMANY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 33. GERMANY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 34. FRANCE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 35. FRANCE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 36. FRANCE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37. UK HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 38. UK HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 39. UK HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 40. ITALY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 41. ITALY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 42. ITALY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43. SPAIN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 44. SPAIN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 45. SPAIN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46. REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 47. REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 48. REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49. EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 50. EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 51. EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 53. JAPAN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 54. JAPAN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 55. JAPAN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 56. CHINA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 57. CHINA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 58. CHINA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 59. AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 60. AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 61. AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62. INDIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 63. INDIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 64. INDIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65. SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 66. SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 67. SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68. REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 69. REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 70. REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 72. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 73. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74. LAMEA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 75. BRAZIL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 76. BRAZIL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 77. BRAZIL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 78. SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 79. SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 80. SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 81. SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 82. SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 83. SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY END USER 2020-2030($MILLION)
TABLE 84. REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 85. REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 86. REST OF LAMEA HEMATOLOGY ANALYZER MARKET, END USER, 2020-2030($MILLION)
TABLE 87. LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 88. LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 89. LAMEA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90. ABBOTT: COMPANY SNAPSHOT
TABLE 91. ABBOTT: OPERATING SEGMENTS
TABLE 92. ABBOTT: PRODUCT PORTFOLIO
TABLE 93. ABBOTT: KEY DEVELOPMENTS
TABLE 94. BIORAD: COMPANY SNAPSHOT
TABLE 95. BIORAD: OPERATING SEGMENTS
TABLE 96. BIORAD: PRODUCT PORTFOLIO
TABLE 97. BOULE: COMPANY SNAPSHOT
TABLE 98. BOULE: OPERATING SEGMENTS
TABLE 99. BOULE: PRODUCT PORTFOLIO
TABLE 100. BOULE: KEY DEVELOPMENTS
TABLE 101. DANAHER: COMPANY SNAPSHOT
TABLE 102. DANAHER: OPERATING SEGMENTS
TABLE 103. DANAHER: PRODUCT PORTFOLIO
TABLE 104. DANAHER: KEY DEVELOPMENTS
TABLE 105. ROCHE: COMPANY SNAPSHOT
TABLE 106. ROCHE: OPEARING SEGMENTS
TABLE 107. ROCHE: PRODUCT PORTFOLIO
TABLE 108. ROCHE: KEY DEVELOPMENTS
TABLE 109. HORIBA: COMPANY SNAPSHOT
TABLE 110. HORIBA: OPERATING SEGMENTS
TABLE 111. HORIBA: PRODUCT PORTFOLIO
TABLE 112. HORIBA: KEY DEVELOPMENTS
TABLE 113. NIHON: COMPANY SNAPSHOT
TABLE 114. NIHON: OPERATING SEGMENTS
TABLE 115. NIHON: PRODUCT PORTFOLIO
TABLE 116. NIHON: KEY DEVELOPMENTS
TABLE 117. SIEMENS: COMPANY SNAPSHOT
TABLE 118. SIEMENS: OPERATING SEGMENTS
TABLE 119. SIEMENS: PRODUCT PORTFOLIO
TABLE 120. SIEMENS: KEY DEVELOPMENTS
TABLE 121. STRATEC: COMPANY SNAPSHOT
TABLE 122. STRATEC: OPERATING SEGMENTS
TABLE 123. STRATEC: PRODUCT PORTFOLIO
TABLE 124. STRATEC: KEY DEVELOPMENTS
TABLE 125. SYSMEX: COMPANY SNAPSHOT
TABLE 126. SYSMEX: OPERATING SEGMENTS
TABLE 127. SYSMEX: PRODUCT PORTFOLIO
TABLE 128. SIEMENS: KEY DEVELOPMENTS
List of Figures
FIGURE 01. HEMATOLOGY ANALYZER MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. HIGH INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. ABBOTT: NET SALES, 2018-2020 ($MILLION)
FIGURE 23. ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24. ABBOTT: REVENUE SHARE BY REGION, 2020(%)
FIGURE 25. BIORAD: NET SALES, 2018-2020 ($MILLION)
FIGURE 26. BIORAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27. BIORAD: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28. BOULE: NET SALES, 2018-2020 ($MILLION)
FIGURE 29. DANAHER: NET SALES, 2018-2020 ($MILLION)
FIGURE 30. DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32. ROCHE: NET SALES, 2018-2020 ($MILLION)
FIGURE 33. ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. ROCHE: REVENUE SHARE BY REGION, 2020(%)
FIGURE 35. HORIBA: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. HORIBA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37. HORIBA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. NIHON: NET SALES, 2019-2021 ($MILLION)
FIGURE 39. NIHON: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 40. NIHON: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 41. SIEMENS: NET SALES, 2018-2020 ($MILLION)
FIGURE 42. SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43. SIEMENS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 44. STRATEC: NET SALES, 2018-2020 ($MILLION)
FIGURE 45. STRATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46. STRATEC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 47. SYSMEX: NET SALES, 2018-2020 ($MILLION)
FIGURE 48. SYSMEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49. SYSMEX: REVENUE SHARE BY REGION, 2020(%)

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages261
PublishedSeptember 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 1962.4 million
Forecasted Market Value ( USD ) by 2030 $ 3941.1 million
Compound Annual Growth Rate7.2%
Regions CoveredGlobal

Related Topics

Related Reports

Hematology Analyzers and Reagents Market Report by Product, Usage Type, Price Range, Application, End User, and Region 2024-2032 - Product Image

Hematology Analyzers and Reagents Market Report by Product, Usage Type, Price Range, Application, End User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Global Hematology Analyzers & Reagents Market by Product & Service (Instrument, Regents, Services), Price Range (High-End Hematology Analyzers, Low-End Hematology Analyzers, Mid-Range Hematology Analyzers), End-User - Forecast 2024-2030 - Product Image

Global Hematology Analyzers & Reagents Market by Product & Service (Instrument, Regents, Services), Price Range (High-End Hematology Analyzers, Low-End Hematology Analyzers, Mid-Range Hematology Analyzers), End-User - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Hematology Analyzer Market - Product Image

Hematology Analyzer Market

  • Report
  • 144 Pages
  • Global
From
Hematology Analyzers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Hematology Analyzers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 120 Pages
  • Global
From
Hematology Analyzer and Reagent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Hematology Analyzer and Reagent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 114 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.